Izumi, Japan

Fujiko Takamura

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fujiko Takamura. Retrieved from https://idiyas.com/inventor/fujiko-takamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fujiko Takamura: Innovator in Pharmaceutical Chemistry

Introduction

Fujiko Takamura is a prominent inventor based in Izumi, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly with her innovative work on compounds that have potential applications in various therapeutic areas.

Latest Patents

Takamura holds a patent for 4,5-diaryloxazole compounds, which are characterized by a specific chemical formula. This invention represents a notable advancement in the development of new pharmaceutical agents.

Career Highlights

Fujiko Takamura is associated with Fujisawa Pharmaceutical Company, Ltd., where she has been instrumental in research and development efforts. Her work has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Throughout her career, Takamura has collaborated with notable colleagues, including Akira Tanaka and Kouji Hattori. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Fujisawa Pharmaceutical Company.

Conclusion

Fujiko Takamura's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…